Current study suggested that the therapeutic effect of BLWE in promoting neurogenesis in the treatment of AD may be achieved by initiating CyclinD1 transcription and then activating the Wnt/β-catenin signaling pathway. Here, CCND1 is linked to Alzheimer disease.